These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272 [TBL] [Abstract][Full Text] [Related]
7. A more specific anticoagulation regimen is required for patients after the cox-maze procedure. Ad N; Henry L; Shuman DJ; Holmes SD Ann Thorac Surg; 2014 Oct; 98(4):1331-8. PubMed ID: 25152383 [TBL] [Abstract][Full Text] [Related]
8. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [TBL] [Abstract][Full Text] [Related]
9. Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients. Podd SJ; Sugihara C; Furniss SS; Sulke N Europace; 2016 Jul; 18(7):1000-5. PubMed ID: 26585596 [TBL] [Abstract][Full Text] [Related]
10. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. Kapa S; Epstein AE; Callans DJ; Garcia FC; Lin D; Bala R; Riley MP; Hutchinson MD; Gerstenfeld EP; Tzou W; Marchlinski FE; Frankel DS; Cooper JM; Supple G; Deo R; Verdino RJ; Patel VV; Dixit S J Cardiovasc Electrophysiol; 2013 Aug; 24(8):875-81. PubMed ID: 23577826 [TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry. Nührich JM; Kuck KH; Andresen D; Steven D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA Clin Res Cardiol; 2015 Jun; 104(6):463-70. PubMed ID: 25537233 [TBL] [Abstract][Full Text] [Related]
12. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk. Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432 [TBL] [Abstract][Full Text] [Related]
13. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation. Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077 [TBL] [Abstract][Full Text] [Related]
14. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393 [TBL] [Abstract][Full Text] [Related]